Moderna, Inc. (MRNA)
218.01
-18.49
(-7.82%)
USD |
NASDAQ |
Oct 16, 16:00
215.19
-2.82
(-1.29%)
After-Hours: 20:00
Moderna Research and Development Expense (Annual) : 2.917B for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 2.917B |
| December 31, 2024 | 4.354B |
| December 31, 2023 | 4.224B |
| December 31, 2022 | 2.947B |
| December 31, 2021 | 1.759B |
| Date | Value |
|---|---|
| December 31, 2020 | 1.339B |
| December 31, 2019 | 465.29M |
| December 31, 2018 | 509.68M |
| December 31, 2017 | 410.46M |
| December 31, 2016 | 274.72M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Revolution Medicines, Inc. | 978.68M |
| Vaxcyte, Inc. | 794.31M |
| Twist Bioscience Corp. | 80.28M |
| BioNTech SE | 2.376B |
| Vir Biotechnology, Inc. | 432.80M |